AI Drug Discovery for Pharma and Biotech

Drug discovery

96

papers

On emerging therapies

Overview

Isolated corpus callosum agenesis (AgCC) is a congenital cerebral malformation involving partial or complete absence of the corpus callosum without major concomitant brain anomalies. Presentation ranges from asymptomatic cases to intellectual disability, seizures, and subtle neuropsychological deficits (e.g., slower interhemispheric processing and reduced complex reasoning). Symptoms may emerge during adolescence as cognitive demands increase. Diagnosis requires neuroimaging, and management focuses on developmental support and symptom monitoring [1][2][6][7][14].

Population

  • Prevalence: ~1 in 4,000 live births [14][18], with 30–75% of cases remaining genetically idiopathic [5][6].

  • Occurs equally across genders and ethnicities; familial forms account for 10–35% of cases [5][9].

Burden

  • Up to 30% experience moderate-severe neurodevelopmental impairments (learning, social skills) [7][14][18].

  • 15–45% develop epilepsy [6][9][13].

  • Long-term psychosocial and economic burden due to lifelong therapies and educational support [2][7][14].

Therapies

  • Multidisciplinary care: Early intervention programs, occupational/physical therapy, and speech therapy [3][7][15].

  • Symptom-based pharmacotherapy (e.g., antiepileptics for seizures) [3][6][9].

  • Annual neurocognitive testing to identify evolving deficits [2][11].

Categories: rare developmental anomalies during embryogenesis, rare neurological diseases

Research Papers

96 drug discovery papers about Isolated corpus callosum agenesis. Recent publications:

96 drug discovery papers about Isolated corpus callosum agenesis. Recent publications:

categories:

Small molecules

small molecules
2026-03-01 | 5PSQ-015 When seizures persist: exploring novel therapeutic options in aicardi syndrome – case report


Background and Importance

Aicardi syndrome is a rare neurodevelopmental disorder characterised by agenesis of the corpus callosum, chorioretinal lacunae, and seizures. No treatments are approved specifically for this condition, and seizure control is complex. Drug-resistant epilepsy carries high morbidity and mortality, with few effective interventions once standard therapies fail.

Aim and Objectives

To describe the clinical evolution of a paediatric patient with Aicardi syndrome and drug-resistant epilepsy, and the impact of cannabidiol and fenfluramine treatment supported by hospital pharmacy intervention. The patient, a female diagnosed at 2 months of age, presented with epileptic seizures unresponsive to multiple anti-seizure medications and dietary therapies.

Material and Methods

From 2010-2024, the patient underwent sequential treatment with lamotrigine, valproic acid, vigabatrin, levetiracetam, primidone, ketogenic diet, rufinamide, topiramate, zonisamide, perampanel, and hydrocortisone, with insufficient seizure control. Hospital pharmacy prepared evidence-based reports to justify the off-label use of cannabidiol (Epidyolex ) and fenfluramine, based on literature in severe epileptic syndromes and clinical need. Dosing was titrated under multidisciplinary follow-up, with seizure frequency, intensity, and tolerability assessed during routine visits.

Results

Cannabidiol initiation (December 2022) achieved marked reduction in tonic–clonic seizures, with sustained partial benefit over 2 years. Persistent reflex seizures prompted dose optimisation and withdrawal of perampanel. Fenfluramine was introduced in 2024 but discontinued after 10 months due to lack of clinical benefit. Cenobamate was also trialled without improvement. No severe adverse effects were observed with cannabidiol or fenfluramine.

Conclusion and Relevance

Cannabidiol provided substantial early seizure reduction with sustained partial benefit over more than 2.5 years of continuous treatment – a follow-up period exceeding that reported in the published literature for Aicardi syndrome and most other epileptic encephalopathies. This long-term observation highlights both the potential durability of cannabidiol’s effect and the need for systematic studies beyond 48 weeks. Fenfluramine use in Aicardi syndrome, with no robust evidence base, was ineffective in our patient. Similarly, cenobamate lacks supporting data in this population and did not improve seizure control. This case underlines the critical role of hospital pharmacy in bridging evidence gaps, enabling access to novel therapies, and ensuring rigorous monitoring in highly refractory contexts. Continuous reassessment and long-term data collection are essential to advance the therapeutic landscape for rare epilepsies.

Conflict of Interest

No conflict of interest


Open article ↗



2026-01-29 | RTN4IP1 mutation and endocrine failure: clinical features and possible benefits of coenzyme Q10.

RTN4IP1 encodes a mitochondrial oxidoreductase essential for coenzyme Q biosynthesis; pathogenic variants have been reported mainly in optic neuropathy and encephalopathy. We describe a 30-year-old woman carrying three novel pathogenic RTN4IP1 variants by exome sequencing (c.1163G>A p.Arg388Gln, c.949A>C p.Met317Leu, and c.1109T>C p.Phe370Ser), who presented with panhypopituitarism, optic nerve hypoplasia, corpus callosum agenesis, bicuspid aortic valve disease, seizures, and muscle pain, already on conventional hormone replacement. Coenzyme Q10 (CoQ10) (200 mg) was administered orally for six months; outcomes were assessed using BPI, WOMAC, TUG, LEFS, grip-strength dynamometry, SF-36, CPK, and LDH, and after six months of daily 200 mg CoQ10, the patient showed marked reductions in pain (BPI 4 → 0.8; -80%) and muscle-damage markers (CPK 254 → 110 U/L) together with gains in grip strength (+49%) and lower-extremity function (LEFS 31 → 60; +94%). SF-36 domains related to physical health showed marked gains, while emotional scores remained stable. This is the first report linking RTN4IP1 mutations to endocrine failure and suggesting a therapeutic role for CoQ10 in mitochondrial-related endocrine disease.

Open article ↗



2025-08-13 | Molecular Navigation: How Axon Guidance Cues Shape Neural Circuits

Precise long-range axon guidance is essential for neural-circuit assembly, and its failure underlies disorders ranging from corpus-callosum agenesis to epilepsy and autism. Four ligand families, including netrins, slits, semaphorins and ephrins, provide combinatorial attract-repel signals that growth cones decode via receptor repertoires and cytoskeletal dynamics. Recent studies show how co-receptors, stoichiometry and second messengers pivot single cues between attraction and repulsion, yielding context-specific trajectories. Guidance programmes re-emerge in the adult brain during learning and after injury, supplying intrinsic blueprints for regeneration, yet their aberrant reactivation can drive maladaptive sprouting and network hyperexcitability. Therapeutic concepts now in pre-clinical testing include Eph inhibitors, exosome-delivered netrin-1 or Sonic Hedgehog, gene editing of guidance receptors and AI-assisted multi-cue scaffolds. This review integrates molecular and translational advances, linking defined wiring errors to clinical phenotypes and proposing how programmable guidance signals could achieve targeted and patient specific repair of damaged neural circuits, thereby laying a conceptual foundation for next generation regenerative neurology that unites developmental biology, biomaterials engineering, and data driven modelling.

Open article ↗



2025-04-25 | Odor localization in structural interhemispheric deficits.

Contrary to all other sensory systems, olfactory information is processed predominantly ipsilaterally. Furthermore, odor localization, based on inter-nostril differences, is usually not possible under controlled conditions. These two observations suggest information exchange between both cerebral hemispheres in the olfactory system, although the exact anatomical substrate remains unknown. This study aimed to identify the anatomical structures necessary for odor localization, with a particular focus on the role of interhemispheric communication. We assessed the ability to localize pure olfactory and mixed olfactory/trigeminal stimuli in 6 participants with structural interhemispheric deficits (including surgical transection or agenesis of the corpus callosum (CC) and agenesis of the CC and anterior commissure (AC, one case)) and compared their performance to 46 healthy controls. Of the six participants with structural interhemispheric deficits, three were unable to localize either stimulus. Two participants performed significantly better than chance for both pure and mixed stimuli, while one participant exhibited the typical localization pattern observed in most controls-accurate localization of the mixed olfactory/trigeminal stimulus but inability to localize the pure olfactory stimulus. Our results suggest that localization of chemosensory stimuli relies, at least in part, on CC, highlighting its role in interhemispheric communication for olfactory processing. The varying odor localization performance observed in participants with agenesis of CC indicates that compensatory mechanisms may be promoted in some cases, potentially preserving normal localization functions despite the absence of major commissural pathways.

Open article ↗



2024-01-31 | Case report: Twice-daily tolvaptan dosing regimen in a challenging case of hyponatremia due to SIAD.

Syndrome of inappropriate antidiuresis (SIAD) is one of the most frequent causes of euvolemic hyponatremia (serum sodium levels < 135 mEq/L) and it represents more than 35% of hyponatremia cases in hospitalized patients. It is characterized by an inappropriate vasopressin (AVP)/antidiuretic hormone (ADH) secretion, which occurs independently from effective serum osmolality or circulating volume, leading to water retention via its action on type 2 vasopressin receptor in the distal renal tubules. Corpus callosum agenesis (CCA) is one of the most common congenital brain defects, which can be associated to alterations in serum sodium levels. This report presents a rare case of chronic hyponatremia associated with SIAD in a woman with CCA, whose correction of serum sodium levels only occurred following twice-daily tolvaptan administration. A 30-year-old female was admitted to our hospital for non-acute hyponatremia with dizziness, headache, distal tremors, and concentration deficits. She had profound hyponatremia (Na 121 mmol/L) with measured plasma hypo-osmolality (259 mOsm/Kg) and urinary osmolality greater than 100 mOsm/Kg (517 mOsm/Kg). She presented clinically as normovolemic. After the exclusion of other causes of normovolemic hyponatremia, such as hypothyroidism and adrenal insufficiency, a diagnosis of SIAD was established. We have ruled out paraneoplastic, inflammatory, and infectious causes, as well as ischemic events. Her medical history showed a CCA and frontal teratoma. We administered tolvaptan initially at a low dosage (15 mg once a day) with persistence of hyponatremia. Therefore, the dosage was first doubled (30 mg once a day) and then increased to 45 mg once a day with an initial improvement in serum sodium levels, although not long-lasting. We therefore tried dividing the 45 mg tolvaptan administration into two doses of 30 mg and 15 mg respectively, using an off-label treatment schedule, thus achieving long-lasting serum sodium levels in the low-normal range associated with a general clinical improvement. This report underlines the importance of the correct diagnosis, management and treatment of SIAD, as well as the need for further studies about the pharmacokinetics and pharmacodynamics of vasopressin receptor antagonists.

Open article ↗



proteins
2026-03-05 | Diffusion tensor imaging of cerebellar peduncles and association tracts in a case of primary complete callosal agenesis.

The corpus callosum is the largest white matter tract in the brain, connecting the left and right cerebral hemispheres. Callosal agenesis is a condition where this tract fails to form during neurodevelopment. Despite this, individuals with callosal agenesis can present as cognitively and behaviorally asymptomatic, retaining some alternate form of interhemispheric communication. Afferent and efferent pathways linking the cortex to the contralateral cerebellum, such as the corticopontocerebellar tract (CPCT) and dentatorubrothalamic tract (DRTT), could serve as compensatory routes in individuals with callosal agenesis, and thus display adaptive changes in white matter structure. To investigate this possibility, we examined a 9-year-old boy with complete callosal agenesis, who performed in line with his peers on IQ and social communication measures, and compared his cerebellar and association tractography to 12 age-matched controls. Diffusion tensor imaging (DTI) metrics were calculated for a whole-brain seed, the cerebellar peduncles, the pontine decussations, the arcuate fasciculus, and the uncinate fasciculus. Whole-brain metrics showed typical fractional anisotropy (FA) but increased mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD) in the callosal agenesis child compared with controls. This pattern was also observed in the right superior cerebellar peduncle. Dorsal pontine fibers exhibited low FA and high RD values in callosal agenesis. The left uncinate and right arcuate fasciculi exhibited a similar pattern of low FA and high RD compared with controls. Overall, this case study characterizes microstructural differences in cerebellar and association tracts in a child with complete callosal agenesis and intact cognitive abilities.

Open article ↗



2026-02-23 | Clinical Presentation of Agenesis of Corpus Callosum Among Children in a Single Tertiary Care Center in Riyadh, Saudi Arabia.

One of the most prevalent brain structural disorders is agenesis of the corpus callosum (ACC). ACC happens when the primary commissural fiber tracts that link the brain hemispheres are absent entirely or partially due to a disturbance of neural cell migration during fetal growth. This research was conducted based on an analytical case-series design. Specifically, a chart review was done by using the patients' charts in King Abdullah Specialized Children's Hospital (KASCH), a tertiary governmental hospital in Riyadh, Saudi Arabia, from 2015 to 2022. A non-random, non-probability consecutive sampling technique was used for this research. Thirty-seven patients were included, comprising 16 males (43.2%) and 21 females (56.8%). The ages ranged from two to 13, with 14 patients being below five years old (37.8%), 20 patients between five years old and 10 years old (54.1%), and three patients above 10 years old (8.1%). Dysmorphic features were present in 25 patients (67.6%), developmental delay in 21 patients (56.8%), seizures in 10 patients (27%), vision impairment in 12 patients (32.4%), and hearing impairment in four patients (10.8%). Cardiac comorbidities were found in 18 patients (48.6%), gastrointestinal comorbidities in 18 patients (48.6%), respiratory comorbidities in 15 patients (40.5%), neurological comorbidities in 26 patients (70.3%), and nephrological comorbidities in 10 patients (27%). MRI was used as a diagnostic tool in 28 patients (75.7%), while nine patients (24.3%) used other diagnostic methods. All comorbidities do not have any significant association with the type of ACC. However, rarely does ACC occur in an isolated manner.

Open article ↗



2025-12-25 | Rare Triad of Midline Craniofacial Defects: A Case Report

Midline craniofacial anomalies are rare malformations that may occur in isolation or as part of syndromic associations. Among them, the coexistence of basal encephalocele, agenesis of the corpus callosum, and Morning Glory Syndrome (MGS) is exceptionally rare, with only a handful of cases described in the literature. We report the case of a 7-year-old female with hypertelorism, cleft lip and palate, and an intraoral swelling. MRI demonstrated sphenoethmoidal encephalocele, complete agenesis of the corpus callosum, right ocular coloboma, and a posterior fossa arachnoid cyst. Fundus examination revealed characteristic features of MGS in the right eye. Genetic testing including whole-exome sequencing, mitochondrial sequencing, and chromosomal microarray was normal, supporting a sporadic occurrence. The patient underwent staged surgical interventions, including Millard’s rotation–advancement cheiloplasty and transcranial repair of the basal encephalocele. Supportive visual management with refractive correction and multidisciplinary rehabilitation was initiated. Basal encephaloceles account for less than 1.5% of all encephaloceles and are frequently associated with midline craniofacial anomalies. MGS, although typically sporadic, may coexist with midline craniofacial and intracranial defects, reflecting a common embryological pathway of failed midline closure. The presence of this triad resembles features of the Sakoda complex. Despite normal genetic results in our case, prior studies implicate genes such as PAX6, OTX2, and SOX2 in similar overlapping phenotypes. MRI remains the gold standard for evaluating intracranial extension and associated anomalies, while CT is essential for delineating the bony defect for surgical planning. This report adds to the scarce literature on the rare triad of sphenoethmoidal encephalocele, corpus callosal agenesis, and MGS. Comprehensive imaging, early surgical repair, supportive ophthalmic care, and multidisciplinary follow-up are essential for optimizing long-term outcomes.

Open article ↗



2025-05-31 | EARLY-ONSET SCHIZOPHRENIA AND AGENESIS OF THE CORPUS CALLOSUM: A CASE REPORT AND LITERATURE REVIEW

This article presents a clinical case of a 17-year-old adolescent with early-onset schizophrenia associated with partial agenesis of the corpus callosum. We discuss the rarity of this association and its importance in the evaluation of neurodevelopmental disorders. We also highlight the diagnostic and therapeutic challenges encountered in this context. Through a review of recent literature, we examine the links between agenesis of the corpus callosum and schizophrenia and explore the neurobiological perspectives of this association.

Open article ↗



2025-04-04 | Learning from a Missed Diagnosis: Complete Agenesis of the Corpus Callosum with benign hydrocephalus

\fancypagestylefirstpage\fancyhf \lhead \chead\rhead \cfootفروردین ماه ۱۴۰۴Title PageArticle type: Case reportTitle of case report: Learning from a Missed Diagnosis: Complete Agenesis of the Corpus Callosum with benign hydrocephalusJE Samaranayake#, SM Kankanamge, P Pirakash, UA Liyanage, Y Mathangasinghe*#, DG Gonsalvez*, N Gunasekera*Dr. Jayami Eshana Samaranayake (MBBS, MRCS)Affiliation: Registrar in General Surgery, Postgraduate Institute of Medicine, University of Colombo.Email: m39899@pgim.cmb.ac.lkORCID ID: https://orcid.org/0000-0001-9849-275XDr. Sandaruwan Madushanka Kankanamge (MBBS)Registrar in General Surgery, Postgraduate Institute of Medicine, University of Colombo.Email: sandaruwanmadushanka114@gmail.comDr. Padmanesan Pirakash (MBBS, MD (Surgery))Senior Registrar in Neurosurgery, Postgraduate Institute of Medicine, University of Colombo.Email: ppirakash@gmail.comDr. Udari Apsara Liyanagae (MBBS, MD (Radiology))Consultant Radiologist, Faculty of Medicine, University of ColomboEmail: udari8@gmail.comDr. David Gonsalvez (PhD)Deputy Director of the Centre for Human Anatomy Education, Head of the Neuroglial Plasticity and Repair Lab, Department of Anatomy and Developmental Biology, Biomedical Discovery Institute, Monash University, AustraliaEmail: david.gonsalvez@monash.eduDr. Yasith Mathangasinghe (MBBS, PhD)Lecturer, Centre for Human Anatomy Education, Department of Anatomy and Developmental Biology, Biomedical Discovery Institute, Monash University, AustraliaEmail: yasith.mathangasinghe1@monash.eduORCID ID: https://orcid.org/0000-0003-4641-5642Dr. Nishantha Gunasekera (MBBS, MD(Surgery))Consultant Neurosurgeon, Department of Neurosurgery, Teaching Hospital Karapitiya.Email: surgnish@yahoo.com*Co-senior authors, #Co-correspondence

Open article ↗



cell therapies
2026-06-14 | Analyses of cellular mosaicism in chimeric mouse brains

The BTBR T+Itpr3^tf/J mouse is one of the most widely used idiopathic models of autism, reproducing core autism-like behaviors together with fixed neuroanatomical traits, most notably complete corpus callosum agenesis and hippocampal alterations. To test whether these traits are cell-autonomous or are imposed by the surrounding tissue environment, we generated inter-strain aggregation chimeras between BTBR and a GFP-expressing C57BL/6 line (B6-GFP), in which every cell is permanently traceable to its strain of origin by GFP (GFP⁺ = B6-derived; GFP⁻ = BTBR-derived). Brains were imaged by confocal microscopy and the strain composition of neurons (NeuroTrace/Nissl) and astrocytes (GFAP) was quantified across the cortex and hippocampus. The study finds that corpus callosum agenesis is rescued in the chimeric environment (a non-cell-autonomous trait), whereas hippocampal neurons and astrocytes segregate by layer in a strain-linked, cell-intrinsic manner. The dataset reports, for each brain area we examined, how many cells came from the B6 strain (green) out of all the cells counted. Each row is one measurement in one brain region of one mouse, and gives the number of B6 (green) cells, the total number of cells, and the percentage that were B6. It covers nine mice (CH1–CH7 plus two pups) and two brain areas — the cortex and the hippocampus (regions CA1, CA2, CA3, and the dentate gyrus) — and reports neurons and astrocytes separately, in both the main cell layer and the molecular layer, for both sides of the brain.

Open article ↗



small molecules
2026-03-01 | 5PSQ-015 When seizures persist: exploring novel therapeutic options in aicardi syndrome – case report


Background and Importance

Aicardi syndrome is a rare neurodevelopmental disorder characterised by agenesis of the corpus callosum, chorioretinal lacunae, and seizures. No treatments are approved specifically for this condition, and seizure control is complex. Drug-resistant epilepsy carries high morbidity and mortality, with few effective interventions once standard therapies fail.

Aim and Objectives

To describe the clinical evolution of a paediatric patient with Aicardi syndrome and drug-resistant epilepsy, and the impact of cannabidiol and fenfluramine treatment supported by hospital pharmacy intervention. The patient, a female diagnosed at 2 months of age, presented with epileptic seizures unresponsive to multiple anti-seizure medications and dietary therapies.

Material and Methods

From 2010-2024, the patient underwent sequential treatment with lamotrigine, valproic acid, vigabatrin, levetiracetam, primidone, ketogenic diet, rufinamide, topiramate, zonisamide, perampanel, and hydrocortisone, with insufficient seizure control. Hospital pharmacy prepared evidence-based reports to justify the off-label use of cannabidiol (Epidyolex ) and fenfluramine, based on literature in severe epileptic syndromes and clinical need. Dosing was titrated under multidisciplinary follow-up, with seizure frequency, intensity, and tolerability assessed during routine visits.

Results

Cannabidiol initiation (December 2022) achieved marked reduction in tonic–clonic seizures, with sustained partial benefit over 2 years. Persistent reflex seizures prompted dose optimisation and withdrawal of perampanel. Fenfluramine was introduced in 2024 but discontinued after 10 months due to lack of clinical benefit. Cenobamate was also trialled without improvement. No severe adverse effects were observed with cannabidiol or fenfluramine.

Conclusion and Relevance

Cannabidiol provided substantial early seizure reduction with sustained partial benefit over more than 2.5 years of continuous treatment – a follow-up period exceeding that reported in the published literature for Aicardi syndrome and most other epileptic encephalopathies. This long-term observation highlights both the potential durability of cannabidiol’s effect and the need for systematic studies beyond 48 weeks. Fenfluramine use in Aicardi syndrome, with no robust evidence base, was ineffective in our patient. Similarly, cenobamate lacks supporting data in this population and did not improve seizure control. This case underlines the critical role of hospital pharmacy in bridging evidence gaps, enabling access to novel therapies, and ensuring rigorous monitoring in highly refractory contexts. Continuous reassessment and long-term data collection are essential to advance the therapeutic landscape for rare epilepsies.

Conflict of Interest

No conflict of interest


Open article ↗



2026-01-29 | RTN4IP1 mutation and endocrine failure: clinical features and possible benefits of coenzyme Q10.

RTN4IP1 encodes a mitochondrial oxidoreductase essential for coenzyme Q biosynthesis; pathogenic variants have been reported mainly in optic neuropathy and encephalopathy. We describe a 30-year-old woman carrying three novel pathogenic RTN4IP1 variants by exome sequencing (c.1163G>A p.Arg388Gln, c.949A>C p.Met317Leu, and c.1109T>C p.Phe370Ser), who presented with panhypopituitarism, optic nerve hypoplasia, corpus callosum agenesis, bicuspid aortic valve disease, seizures, and muscle pain, already on conventional hormone replacement. Coenzyme Q10 (CoQ10) (200 mg) was administered orally for six months; outcomes were assessed using BPI, WOMAC, TUG, LEFS, grip-strength dynamometry, SF-36, CPK, and LDH, and after six months of daily 200 mg CoQ10, the patient showed marked reductions in pain (BPI 4 → 0.8; -80%) and muscle-damage markers (CPK 254 → 110 U/L) together with gains in grip strength (+49%) and lower-extremity function (LEFS 31 → 60; +94%). SF-36 domains related to physical health showed marked gains, while emotional scores remained stable. This is the first report linking RTN4IP1 mutations to endocrine failure and suggesting a therapeutic role for CoQ10 in mitochondrial-related endocrine disease.

Open article ↗



2025-08-13 | Molecular Navigation: How Axon Guidance Cues Shape Neural Circuits

Precise long-range axon guidance is essential for neural-circuit assembly, and its failure underlies disorders ranging from corpus-callosum agenesis to epilepsy and autism. Four ligand families, including netrins, slits, semaphorins and ephrins, provide combinatorial attract-repel signals that growth cones decode via receptor repertoires and cytoskeletal dynamics. Recent studies show how co-receptors, stoichiometry and second messengers pivot single cues between attraction and repulsion, yielding context-specific trajectories. Guidance programmes re-emerge in the adult brain during learning and after injury, supplying intrinsic blueprints for regeneration, yet their aberrant reactivation can drive maladaptive sprouting and network hyperexcitability. Therapeutic concepts now in pre-clinical testing include Eph inhibitors, exosome-delivered netrin-1 or Sonic Hedgehog, gene editing of guidance receptors and AI-assisted multi-cue scaffolds. This review integrates molecular and translational advances, linking defined wiring errors to clinical phenotypes and proposing how programmable guidance signals could achieve targeted and patient specific repair of damaged neural circuits, thereby laying a conceptual foundation for next generation regenerative neurology that unites developmental biology, biomaterials engineering, and data driven modelling.

Open article ↗



2025-04-25 | Odor localization in structural interhemispheric deficits.

Contrary to all other sensory systems, olfactory information is processed predominantly ipsilaterally. Furthermore, odor localization, based on inter-nostril differences, is usually not possible under controlled conditions. These two observations suggest information exchange between both cerebral hemispheres in the olfactory system, although the exact anatomical substrate remains unknown. This study aimed to identify the anatomical structures necessary for odor localization, with a particular focus on the role of interhemispheric communication. We assessed the ability to localize pure olfactory and mixed olfactory/trigeminal stimuli in 6 participants with structural interhemispheric deficits (including surgical transection or agenesis of the corpus callosum (CC) and agenesis of the CC and anterior commissure (AC, one case)) and compared their performance to 46 healthy controls. Of the six participants with structural interhemispheric deficits, three were unable to localize either stimulus. Two participants performed significantly better than chance for both pure and mixed stimuli, while one participant exhibited the typical localization pattern observed in most controls-accurate localization of the mixed olfactory/trigeminal stimulus but inability to localize the pure olfactory stimulus. Our results suggest that localization of chemosensory stimuli relies, at least in part, on CC, highlighting its role in interhemispheric communication for olfactory processing. The varying odor localization performance observed in participants with agenesis of CC indicates that compensatory mechanisms may be promoted in some cases, potentially preserving normal localization functions despite the absence of major commissural pathways.

Open article ↗



2024-01-31 | Case report: Twice-daily tolvaptan dosing regimen in a challenging case of hyponatremia due to SIAD.

Syndrome of inappropriate antidiuresis (SIAD) is one of the most frequent causes of euvolemic hyponatremia (serum sodium levels < 135 mEq/L) and it represents more than 35% of hyponatremia cases in hospitalized patients. It is characterized by an inappropriate vasopressin (AVP)/antidiuretic hormone (ADH) secretion, which occurs independently from effective serum osmolality or circulating volume, leading to water retention via its action on type 2 vasopressin receptor in the distal renal tubules. Corpus callosum agenesis (CCA) is one of the most common congenital brain defects, which can be associated to alterations in serum sodium levels. This report presents a rare case of chronic hyponatremia associated with SIAD in a woman with CCA, whose correction of serum sodium levels only occurred following twice-daily tolvaptan administration. A 30-year-old female was admitted to our hospital for non-acute hyponatremia with dizziness, headache, distal tremors, and concentration deficits. She had profound hyponatremia (Na 121 mmol/L) with measured plasma hypo-osmolality (259 mOsm/Kg) and urinary osmolality greater than 100 mOsm/Kg (517 mOsm/Kg). She presented clinically as normovolemic. After the exclusion of other causes of normovolemic hyponatremia, such as hypothyroidism and adrenal insufficiency, a diagnosis of SIAD was established. We have ruled out paraneoplastic, inflammatory, and infectious causes, as well as ischemic events. Her medical history showed a CCA and frontal teratoma. We administered tolvaptan initially at a low dosage (15 mg once a day) with persistence of hyponatremia. Therefore, the dosage was first doubled (30 mg once a day) and then increased to 45 mg once a day with an initial improvement in serum sodium levels, although not long-lasting. We therefore tried dividing the 45 mg tolvaptan administration into two doses of 30 mg and 15 mg respectively, using an off-label treatment schedule, thus achieving long-lasting serum sodium levels in the low-normal range associated with a general clinical improvement. This report underlines the importance of the correct diagnosis, management and treatment of SIAD, as well as the need for further studies about the pharmacokinetics and pharmacodynamics of vasopressin receptor antagonists.

Open article ↗



proteins
2026-03-05 | Diffusion tensor imaging of cerebellar peduncles and association tracts in a case of primary complete callosal agenesis.

The corpus callosum is the largest white matter tract in the brain, connecting the left and right cerebral hemispheres. Callosal agenesis is a condition where this tract fails to form during neurodevelopment. Despite this, individuals with callosal agenesis can present as cognitively and behaviorally asymptomatic, retaining some alternate form of interhemispheric communication. Afferent and efferent pathways linking the cortex to the contralateral cerebellum, such as the corticopontocerebellar tract (CPCT) and dentatorubrothalamic tract (DRTT), could serve as compensatory routes in individuals with callosal agenesis, and thus display adaptive changes in white matter structure. To investigate this possibility, we examined a 9-year-old boy with complete callosal agenesis, who performed in line with his peers on IQ and social communication measures, and compared his cerebellar and association tractography to 12 age-matched controls. Diffusion tensor imaging (DTI) metrics were calculated for a whole-brain seed, the cerebellar peduncles, the pontine decussations, the arcuate fasciculus, and the uncinate fasciculus. Whole-brain metrics showed typical fractional anisotropy (FA) but increased mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD) in the callosal agenesis child compared with controls. This pattern was also observed in the right superior cerebellar peduncle. Dorsal pontine fibers exhibited low FA and high RD values in callosal agenesis. The left uncinate and right arcuate fasciculi exhibited a similar pattern of low FA and high RD compared with controls. Overall, this case study characterizes microstructural differences in cerebellar and association tracts in a child with complete callosal agenesis and intact cognitive abilities.

Open article ↗



2026-02-23 | Clinical Presentation of Agenesis of Corpus Callosum Among Children in a Single Tertiary Care Center in Riyadh, Saudi Arabia.

One of the most prevalent brain structural disorders is agenesis of the corpus callosum (ACC). ACC happens when the primary commissural fiber tracts that link the brain hemispheres are absent entirely or partially due to a disturbance of neural cell migration during fetal growth. This research was conducted based on an analytical case-series design. Specifically, a chart review was done by using the patients' charts in King Abdullah Specialized Children's Hospital (KASCH), a tertiary governmental hospital in Riyadh, Saudi Arabia, from 2015 to 2022. A non-random, non-probability consecutive sampling technique was used for this research. Thirty-seven patients were included, comprising 16 males (43.2%) and 21 females (56.8%). The ages ranged from two to 13, with 14 patients being below five years old (37.8%), 20 patients between five years old and 10 years old (54.1%), and three patients above 10 years old (8.1%). Dysmorphic features were present in 25 patients (67.6%), developmental delay in 21 patients (56.8%), seizures in 10 patients (27%), vision impairment in 12 patients (32.4%), and hearing impairment in four patients (10.8%). Cardiac comorbidities were found in 18 patients (48.6%), gastrointestinal comorbidities in 18 patients (48.6%), respiratory comorbidities in 15 patients (40.5%), neurological comorbidities in 26 patients (70.3%), and nephrological comorbidities in 10 patients (27%). MRI was used as a diagnostic tool in 28 patients (75.7%), while nine patients (24.3%) used other diagnostic methods. All comorbidities do not have any significant association with the type of ACC. However, rarely does ACC occur in an isolated manner.

Open article ↗



2025-12-25 | Rare Triad of Midline Craniofacial Defects: A Case Report

Midline craniofacial anomalies are rare malformations that may occur in isolation or as part of syndromic associations. Among them, the coexistence of basal encephalocele, agenesis of the corpus callosum, and Morning Glory Syndrome (MGS) is exceptionally rare, with only a handful of cases described in the literature. We report the case of a 7-year-old female with hypertelorism, cleft lip and palate, and an intraoral swelling. MRI demonstrated sphenoethmoidal encephalocele, complete agenesis of the corpus callosum, right ocular coloboma, and a posterior fossa arachnoid cyst. Fundus examination revealed characteristic features of MGS in the right eye. Genetic testing including whole-exome sequencing, mitochondrial sequencing, and chromosomal microarray was normal, supporting a sporadic occurrence. The patient underwent staged surgical interventions, including Millard’s rotation–advancement cheiloplasty and transcranial repair of the basal encephalocele. Supportive visual management with refractive correction and multidisciplinary rehabilitation was initiated. Basal encephaloceles account for less than 1.5% of all encephaloceles and are frequently associated with midline craniofacial anomalies. MGS, although typically sporadic, may coexist with midline craniofacial and intracranial defects, reflecting a common embryological pathway of failed midline closure. The presence of this triad resembles features of the Sakoda complex. Despite normal genetic results in our case, prior studies implicate genes such as PAX6, OTX2, and SOX2 in similar overlapping phenotypes. MRI remains the gold standard for evaluating intracranial extension and associated anomalies, while CT is essential for delineating the bony defect for surgical planning. This report adds to the scarce literature on the rare triad of sphenoethmoidal encephalocele, corpus callosal agenesis, and MGS. Comprehensive imaging, early surgical repair, supportive ophthalmic care, and multidisciplinary follow-up are essential for optimizing long-term outcomes.

Open article ↗



2025-05-31 | EARLY-ONSET SCHIZOPHRENIA AND AGENESIS OF THE CORPUS CALLOSUM: A CASE REPORT AND LITERATURE REVIEW

This article presents a clinical case of a 17-year-old adolescent with early-onset schizophrenia associated with partial agenesis of the corpus callosum. We discuss the rarity of this association and its importance in the evaluation of neurodevelopmental disorders. We also highlight the diagnostic and therapeutic challenges encountered in this context. Through a review of recent literature, we examine the links between agenesis of the corpus callosum and schizophrenia and explore the neurobiological perspectives of this association.

Open article ↗



2025-04-04 | Learning from a Missed Diagnosis: Complete Agenesis of the Corpus Callosum with benign hydrocephalus

\fancypagestylefirstpage\fancyhf \lhead \chead\rhead \cfootفروردین ماه ۱۴۰۴Title PageArticle type: Case reportTitle of case report: Learning from a Missed Diagnosis: Complete Agenesis of the Corpus Callosum with benign hydrocephalusJE Samaranayake#, SM Kankanamge, P Pirakash, UA Liyanage, Y Mathangasinghe*#, DG Gonsalvez*, N Gunasekera*Dr. Jayami Eshana Samaranayake (MBBS, MRCS)Affiliation: Registrar in General Surgery, Postgraduate Institute of Medicine, University of Colombo.Email: m39899@pgim.cmb.ac.lkORCID ID: https://orcid.org/0000-0001-9849-275XDr. Sandaruwan Madushanka Kankanamge (MBBS)Registrar in General Surgery, Postgraduate Institute of Medicine, University of Colombo.Email: sandaruwanmadushanka114@gmail.comDr. Padmanesan Pirakash (MBBS, MD (Surgery))Senior Registrar in Neurosurgery, Postgraduate Institute of Medicine, University of Colombo.Email: ppirakash@gmail.comDr. Udari Apsara Liyanagae (MBBS, MD (Radiology))Consultant Radiologist, Faculty of Medicine, University of ColomboEmail: udari8@gmail.comDr. David Gonsalvez (PhD)Deputy Director of the Centre for Human Anatomy Education, Head of the Neuroglial Plasticity and Repair Lab, Department of Anatomy and Developmental Biology, Biomedical Discovery Institute, Monash University, AustraliaEmail: david.gonsalvez@monash.eduDr. Yasith Mathangasinghe (MBBS, PhD)Lecturer, Centre for Human Anatomy Education, Department of Anatomy and Developmental Biology, Biomedical Discovery Institute, Monash University, AustraliaEmail: yasith.mathangasinghe1@monash.eduORCID ID: https://orcid.org/0000-0003-4641-5642Dr. Nishantha Gunasekera (MBBS, MD(Surgery))Consultant Neurosurgeon, Department of Neurosurgery, Teaching Hospital Karapitiya.Email: surgnish@yahoo.com*Co-senior authors, #Co-correspondence

Open article ↗



cell therapies
2026-06-14 | Analyses of cellular mosaicism in chimeric mouse brains

The BTBR T+Itpr3^tf/J mouse is one of the most widely used idiopathic models of autism, reproducing core autism-like behaviors together with fixed neuroanatomical traits, most notably complete corpus callosum agenesis and hippocampal alterations. To test whether these traits are cell-autonomous or are imposed by the surrounding tissue environment, we generated inter-strain aggregation chimeras between BTBR and a GFP-expressing C57BL/6 line (B6-GFP), in which every cell is permanently traceable to its strain of origin by GFP (GFP⁺ = B6-derived; GFP⁻ = BTBR-derived). Brains were imaged by confocal microscopy and the strain composition of neurons (NeuroTrace/Nissl) and astrocytes (GFAP) was quantified across the cortex and hippocampus. The study finds that corpus callosum agenesis is rescued in the chimeric environment (a non-cell-autonomous trait), whereas hippocampal neurons and astrocytes segregate by layer in a strain-linked, cell-intrinsic manner. The dataset reports, for each brain area we examined, how many cells came from the B6 strain (green) out of all the cells counted. Each row is one measurement in one brain region of one mouse, and gives the number of B6 (green) cells, the total number of cells, and the percentage that were B6. It covers nine mice (CH1–CH7 plus two pups) and two brain areas — the cortex and the hippocampus (regions CA1, CA2, CA3, and the dentate gyrus) — and reports neurons and astrocytes separately, in both the main cell layer and the molecular layer, for both sides of the brain.

Open article ↗



Access all drug discovery papers and probability of success in trials forecasts:

Access all drug discovery papers and probability of success in trials forecasts:

Drug Discovery Landscape

0 orphan drug designations.

0 orphan drug designations.

Explority AI logo

228 Park Ave S,
New York, USA.

At Explority, we build first-of-its-kind AI to bring clarity to the earliest and riskiest stages of pharmaceutical research by forecasting which therapies are most likely to succeed. Explority AI web and mobile applications are properties of the Explority AI Inc., a company registered in the United States (File No. 10320493).
For all questions: support@explority.ai

Copyright © 2026 Explority AI Inc.

Explority AI logo

228 Park Ave S,
New York, USA.

At Explority, we build first-of-its-kind AI to bring clarity to the earliest and riskiest stages of pharmaceutical research by forecasting which therapies are most likely to succeed. Explority AI web and mobile applications are properties of the Explority AI Inc., a company registered in the United States (File No. 10320493).
For all questions: support@explority.ai

Copyright © 2026 Explority AI Inc.

Explority AI logo

228 Park Ave S,
New York, USA.

At Explority, we build first-of-its-kind AI to bring clarity to the earliest and riskiest stages of pharmaceutical research by forecasting which therapies are most likely to succeed. Explority AI web and mobile applications are properties of the Explority AI Inc., a company registered in the United States (File No. 10320493).
For all questions: support@explority.ai

Copyright © 2026 Explority AI Inc.